PLIANT THERAPEUTICS, INC. Public Float
PLIANT THERAPEUTICS, INC. (PLRX) had Public Float of $69.54 million as of 2025-06-30, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-11
- 2025-06-30: Entity Public Float $69.54M.
- 2024-06-30: Entity Public Float $607.61M.
- 2023-06-30: Entity Public Float $1.01B.
- 2022-06-30: Entity Public Float $281.51M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $69.54M 10-K · filed 2026-03-11 |
| 2024-06-30 | $607.61M 10-K · filed 2025-03-03 |
| 2023-06-30 | $1.01B 10-K · filed 2024-02-27 |
| 2022-06-30 | $281.51M 10-K · filed 2023-03-09 |
| 2021-06-30 | $751.81M 10-K/A · filed 2022-05-27 |
| 2020-06-30 | $855.89M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |